PROKIDNEY CORP. — Investor Relations & Filings
Filings indexed
369
across all filing types
Latest filing
2026-04-17
Annual Report
Country
US
United States of America
Listing
US
PROK
ProKidney Corp. is a late clinical-stage biotechnology company developing a proprietary, first-in-class cell therapy platform for the treatment of advanced Chronic Kidney Disease (CKD). Its lead investigational candidate, rilparencel, is an autologous therapy derived from a patient's own kidney cells, which are obtained via a standard biopsy. The therapeutic approach aims to preserve remaining kidney function. Rilparencel is being evaluated for its potential to slow disease progression, with the goal of delaying or eliminating the need for dialysis in patients with limited treatment options.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - PROKIDNEY CORP. (0001850270) (Filer) | 2026-04-17 | English | |
| S-8 - PROKIDNEY CORP. (0001850270) (Filer) | 2026-03-18 | English | |
| 8-K - PROKIDNEY CORP. (0001850270) (Filer) | 2026-03-18 | English | |
| 4 - PROKIDNEY CORP. (0001850270) (Filer) | 2026-03-03 | English | |
| 4 - PROKIDNEY CORP. (0001850270) (Filer) | 2026-03-03 | English | |
| 4 - PROKIDNEY CORP. (0001850270) (Filer) | 2026-03-03 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 34662031 | ARS - PROKIDNEY CORP. (0001850270) (Filer) | 2026-04-17 | English | ||
| 32979112 | S-8 - PROKIDNEY CORP. (0001850270) (Filer) | 2026-03-18 | English | ||
| 32979308 | 8-K - PROKIDNEY CORP. (0001850270) (Filer) | 2026-03-18 | English | ||
| 32899780 | 4 - PROKIDNEY CORP. (0001850270) (Filer) | 2026-03-03 | English | ||
| 32899781 | 4 - PROKIDNEY CORP. (0001850270) (Filer) | 2026-03-03 | English | ||
| 32899782 | 4 - PROKIDNEY CORP. (0001850270) (Filer) | 2026-03-03 | English | ||
| 32899783 | 4 - PROKIDNEY CORP. (0001850270) (Filer) | 2026-03-03 | English | ||
| 32063872 | 8-K Filing | 2026-02-02 | English | ||
| 13404633 | 8-K | 2026-01-12 | English | ||
|
2025
6 filings
| |||||
| 13404634 | Regulatory Filings 2025 | 2025-11-19 | English | ||
| 13404629 | 4 | 2025-11-14 | English | ||
| 13404630 | Regulatory Filings 2025 | 2025-11-12 | English | ||
| 13404631 | Regulatory Filings 2025 | 2025-11-12 | English | ||
| 13404632 | 8-K | 2025-11-10 | English | ||
| 13404639 | 10-Q | 2025-11-10 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Apellis Pharmaceuticals, Inc.
Biopharmaceutical company developing therapies by targeting…
|
APLS | US | Manufacturing |
|
Apeloa Pharmaceutical Co.,Ltd.
Integrated provider of APIs, CDMO services, and finished dr…
|
000739 | CN | Manufacturing |
|
ApicHope Pharmaceutical Group Co.,Ltd
Pharmaceutical firm focused on pediatric, chronic, and card…
|
300723 | CN | Manufacturing |
|
Apimeds Pharmaceuticals US, Inc.
Clinical-stage biopharma developing a bee venom drug and AI…
|
APUS | US | Manufacturing |
|
Apogee Therapeutics, Inc.
Clinical-stage biotech developing biologics for immunologic…
|
APGE | US | Manufacturing |
|
Apollomics Inc.
Clinical-stage biotech developing innovative oncology and c…
|
APLM | US | Manufacturing |
|
Apontis Pharma AG
Develops and markets fixed-dose combination drugs (Single P…
|
APPH | DE | Manufacturing |
|
Appili Therapeutics Inc.
Biopharmaceutical company developing novel medicines for in…
|
APLI | CA | Manufacturing |
|
Applied BioCode Corporation
Develops and manufactures high-throughput multiplex molecul…
|
6598 | TW | Manufacturing |
|
Applied Therapeutics, Inc.
Clinical-stage biopharma developing novel drugs for rare me…
|
APLT | US | Manufacturing |
PROKIDNEY CORP. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32485/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32485 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32485 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32485 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32485}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PROKIDNEY CORP. (id: 32485)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.